Bangalore January 04, 2014: Elder Pharmaceuticals Ltd (EPL), a drug firm plans to expand its horizons by focusing on brand building and plans to enter into newer therapeutic areas. The firm has plans to build and focus on their domestic market of anti-infectives and also expand its business in Europe and in the UK. The drug company also aims to strengthen its in-licence portfolio.
Along with these expansion plans, Elder pharma also prepares to explore the possibility of venturing into new therapeutic areas. As the firm expects an increase in its revenues, it aims at restructuring and restrategising its brands. While the company has already been seeing profits with its division of anti-infectives, the additional areas can prove to be more beneficial.
Now, Elder pharma aims at focusing on increasing its presence in the areas of injectables and anti-infectives to continue with the company’s growth. The company would additionally focus on creating a brand leadership in a particular segment by creating a product in a therapeutic category and develop its own portfolio. The other therapeutic areas that the company aims to concentrate on include neurological and cardio-vascular segments. -IGMPI
